| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |